A summary of supplying therapeutic goods in Australia
Medicinal cannabis - Changes to Special Access Scheme (SAS) and Authorised Prescriber applications
TGA regulatory compliance
Prescribing therapeutic vapes: overview of the regulatory changes
TGA Webinar: Unique Device Identification #1
Market Access in Australia – leveraging international approvals for TGA registrations
The role of the TGA: Information for health professionals
TGA Medical Device Changes in Australia
TGA Webinar: Consumer Medicine Information template changes
Change to classification of MDMA and psilocybin to enable prescribing by authorised psychiatrists
EU MDR Transition, Webinar 2: Manufacturer Evidence and Variations to the ARTG
TGA Webinar: Regulation of Software As a Medical Device
Webinar: Good Manufacturing Practice (GMP)
Insights from the TGA Good Clinical Practice (GCP) Inspection Program
Webinar - Prescribing therapeutic vapes overview of the regulatory changes
Presentation: updates to CTN form and first-in-human high-risk medical device clinical trials
SME Assist ‘Meeting Your Obligations’ workshop, Sydney
Good Clinical Practice GCP inspection program for clinical trials of medicines, biological
Webinar (May 2016): Medical Device Regulations in Australia
TGA Webinar: Presentation on proposed changes to nicotine supply
